David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
CALL
Trip.com Group
TCOM
$29B
| $30.7M | 0.05% |
581,700
+8,900
| +2% | +$483K |
|
452
Yum China
YUMC
$16.7B
| $30.5M | 0.05% |
762,434
-2,903,682
| -79% | -$108M |
|
|
ARRS
453
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $30.5M | 0.05% |
1,069,405
+182,498
| +21% | +$5.05M |
|
454
PUT
Delta Air Lines
DAL
$54.2B
| $30.4M | 0.05% |
631,000
+182,200
| +41% | +$9.08M |
|
|
UCTT
455
Ultra Clean Holdings
UCTT
$3.3B
| $30.4M | 0.05% |
992,972
+160,378
| +19% | +$3.79M |
|
456
Allstate
ALL
$65.8B
| $30.3M | 0.05% |
329,946
-302,997
| -48% | -$27.5M |
|
457
O'Reilly Automotive
ORLY
$73.4B
| $30.2M | 0.05% |
2,103,030
+1,239,300
| +143% | +$16.4M |
|
458
CALL
Charter Communications
CHTR
$17.9B
| $30M | 0.05% |
82,600
+35,000
| +74% | +$13M |
|
459
Ferrari
RACE
$74.6B
| $29.9M | 0.05% |
270,701
+168,053
| +164% | +$17.9M |
|
|
CVSA
460
Covista Inc
CVSA
$4.52B
| $29.8M | 0.05% |
831,675
+312,072
| +60% | +$10.7M |
|
|
TWTR
461
PUT
DELISTED
Twitter, Inc.
TWTR
| $29.6M | 0.05% |
1,755,800
+1,426,800
| +434% | +$24.9M |
|
462
CNX Resources
CNX
$5.4B
| $29.6M | 0.05% |
2,098,158
+1,017,078
| +94% | +$13.1M |
|
463
Labcorp
LH
$27.5B
| $29.3M | 0.05% |
225,996
-146,248
| -39% | -$19.5M |
|
464
Tower Semiconductor
TSEM
$23.9B
| $29.3M | 0.04% |
951,281
-468,893
| -33% | -$12.8M |
|
465
Lear
LEA
$8.18B
| $29.2M | 0.04% |
+168,631
| New | +$25.5M |
|
466
Moog Inc Class A
MOG.A
$12B
| $29.1M | 0.04% |
348,721
-40,700
| -10% | -$3.08M |
|
467
CALL
Wynn Resorts
WYNN
$10.2B
| $29M | 0.04% |
194,900
-49,500
| -20% | -$6.75M |
|
|
CBPX
468
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $29M | 0.04% |
1,116,361
-90,055
| -7% | -$2.08M |
|
|
AGN
469
DELISTED
Allergan plc
AGN
| $28.9M | 0.04% |
141,173
-8,554
| -6% | -$1.99M |
|
470
PUT
Biogen
BIIB
$32.2B
| $28.9M | 0.04% |
92,400
-12,700
| -12% | -$3.76M |
|
|
JNPR
471
DELISTED
Juniper Networks
JNPR
| $28.9M | 0.04% |
1,038,847
-306,893
| -23% | -$8.59M |
|
472
CALL
Amazon
AMZN
$2.83T
| $28.8M | 0.04% |
600,000
-568,000
| -49% | -$27.9M |
|
473
Melco Resorts & Entertainment
MLCO
$2.08B
| $28.6M | 0.04% |
1,187,589
+230,681
| +24% | +$5.01M |
|
474
CALL
Micron Technology
MU
$1.03T
| $28.5M | 0.04% |
725,200
-7,600
| -1% | -$240K |
|
475
Brookdale Senior Living
BKD
$2.89B
| $28.4M | 0.04% |
2,678,899
+1,166,879
| +77% | +$14.8M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.